BSCL2 Antikörper (AA 263-354)
(2 Referenzen)-
- Target Alle BSCL2 Antikörper anzeigen
- BSCL2 (Berardinelli-Seip Congenital Lipodystrophy 2 (Seipin) (BSCL2))
-
Bindungsspezifität
- AA 263-354
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser BSCL2 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA
- Verwendungszweck
- Mouse polyclonal antibody raised against a partial recombinant BSCL2.
- Sequenz
- WPRHRFSLQV NIRKRDNSRK EVQRRISAHQ PGPEGQEEST PQSDVTEDGE SPEDPSGTEG QLSEEEKPDQ QPLSGEEELE PEASDGSGSW ED
- Kreuzreaktivität
- Human
- Produktmerkmale
- Antibody Reactive Against Recombinant Protein.
- Immunogen
- BSCL2 (NP_116056, 263 a.a. ~ 354 a.a) partial recombinant protein with GST tag.
-
anti-Berardinelli-Seip Congenital Lipodystrophy 2 (Seipin) (BSCL2) (AA 1-400) antibody
BSCL2 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Berardinelli-Seip Congenital Lipodystrophy 2 (Seipin) (BSCL2) (AA 50-150) antibodyBSCL2 Reaktivität: Human WB, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Berardinelli-Seip Congenital Lipodystrophy 2 (Seipin) (BSCL2) (AA 78-107), (N-Term) antibodyBSCL2 Reaktivität: Human, Maus WB, IHC (p) Wirt: Kaninchen Polyclonal RB19045 unconjugated
anti-Berardinelli-Seip Congenital Lipodystrophy 2 (Seipin) (BSCL2) (AA 259-357) antibodyBSCL2 Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 1G4 unconjugated
anti-Berardinelli-Seip Congenital Lipodystrophy 2 (Seipin) (BSCL2) (AA 259-357) antibodyBSCL2 Reaktivität: Human WB, ELISA Wirt: Maus Polyclonal unconjugated
anti-Berardinelli-Seip Congenital Lipodystrophy 2 (Seipin) (BSCL2) (AA 362-410) antibodyBSCL2 Reaktivität: Human, Maus, Ratte, Rind (Kuh), Hund, Kaninchen, Affe, Xenopus laevis WB Wirt: Kaninchen Polyclonal unconjugated
anti-Berardinelli-Seip Congenital Lipodystrophy 2 (Seipin) (BSCL2) (C-Term) antibodyBSCL2 Reaktivität: Human, Maus, Ratte, Rind (Kuh), Hund, Kaninchen, Pferd WB Wirt: Kaninchen Polyclonal unconjugated
anti-Berardinelli-Seip Congenital Lipodystrophy 2 (Seipin) (BSCL2) (AA 85-115), (N-Term) antibodyBSCL2 Reaktivität: Human WB, IHC (p), EIA Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- 50 % glycerol
- Handhabung
- Aliquot to avoid repeated freezing and thawing.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
: "Adipose-specific knockout of SEIPIN/BSCL2 results in progressive lipodystrophy." in: Diabetes, Vol. 63, Issue 7, pp. 2320-31, (2014) (PubMed).
: "Overexpression of a short human seipin/BSCL2 isoform in mouse adipose tissue results in mild lipodystrophy." in: American journal of physiology. Endocrinology and metabolism, Vol. 302, Issue 6, pp. E705-13, (2012) (PubMed).
-
: "Adipose-specific knockout of SEIPIN/BSCL2 results in progressive lipodystrophy." in: Diabetes, Vol. 63, Issue 7, pp. 2320-31, (2014) (PubMed).
-
- Target
- BSCL2 (Berardinelli-Seip Congenital Lipodystrophy 2 (Seipin) (BSCL2))
- Andere Bezeichnung
- BSCL2 (BSCL2 Produkte)
- Synonyme
- GNG3LG antikoerper, HMN5 antikoerper, SPG17 antikoerper, 2900097C17Rik antikoerper, AI046355 antikoerper, Gng3lg antikoerper, BSCL2, seipin lipid droplet biogenesis associated antikoerper, Berardinelli-Seip congenital lipodystrophy 2 (seipin) antikoerper, BSCL2 antikoerper, Bscl2 antikoerper
- Hintergrund
-
Full Gene Name: Bernardinelli-Seip congenital lipodystrophy 2 (seipin)
Synonyms: GNG3LG,HMN5,MGC4694,SPG17 - Gen-ID
- 26580
- NCBI Accession
- NM_032667
-
